When is vitamin K supplementation indicated and what are the recommended dosing regimens for deficiency, warfarin reversal, and newborn prophylaxis?

Vitamin K Supplementation: Indications and Dosing

Oral vitamin K is the preferred route for warfarin reversal in most clinical scenarios due to superior safety and predictable efficacy, while intramuscular administration of 1 mg at birth is the gold standard for newborn prophylaxis. 1

Warfarin Reversal in Adults

INR 5-9 Without Bleeding

• Administer 1-2.5 mg oral vitamin K 2
• Withhold 1-2 warfarin doses and resume at lower dose when INR therapeutic 2
• This approach is preferred for patients at increased bleeding risk 2

INR >9 Without Bleeding

• Give 3-5 mg oral vitamin K 2
• Expect INR reduction within 24-48 hours 2
• Monitor INR closely and repeat 1-2 mg if still elevated at 24 hours 2

Life-Threatening Bleeding or Emergency Surgery

• Administer 5-10 mg IV vitamin K diluted in 25-50 mL normal saline over 15-30 minutes 2, 1, 3
• Must be combined with 4-factor prothrombin complex concentrate (4F-PCC) for immediate reversal 2
• Fresh frozen plasma is an alternative if 4F-PCC unavailable, though less effective 2
• IV administration produces response in 4-6 hours versus 18-24 hours for oral 2

Critical Dosing Principles

• Avoid subcutaneous administration—absorption is unpredictable and response delayed 2, 1
• High doses (≥10 mg) may cause warfarin resistance for up to one week 2
• Slow IV infusion is essential to minimize anaphylaxis risk 2, 1
• Recent evidence suggests ultra-low doses (0.25-0.5 mg IV) may be sufficient for INR 4-6 when cautious reversal is needed 4

Perioperative Management

For patients with mechanical heart valves requiring surgery:

• Stop warfarin 2-4 days preoperatively to achieve INR <1.5 2
• Low-risk patients (bileaflet aortic valve, no other risk factors) do not require bridging anticoagulation 2
• High-risk patients (mechanical mitral valve, AF, prior thromboembolism) require bridging with UFH or LMWH 2
• If emergency reversal needed: use fresh frozen plasma or prothrombin complex concentrate plus low-dose (1-2 mg) oral vitamin K only—higher doses complicate post-procedure anticoagulation 2

Newborn Prophylaxis

Term Infants

The recommended regimen is 1 mg intramuscular vitamin K once at birth 5, 6—this is the most effective strategy to prevent all forms of vitamin K deficiency bleeding (VKDB) 5, 6

If parents refuse IM administration:

• Give 2 mg oral vitamin K at birth 5, 6
• Followed by 1-2 mg oral weekly for 3 months if breastfed 5
• Alternative: 2 mg oral at birth, 2 mg at 4-6 days, and 2 mg at 4-6 weeks 6
• Document parental refusal due to late VKDB risk 6

Preterm Infants (<32 weeks)

• Give 1 mg intramuscular at birth 5
• If IM impossible: 0.5 mg IV once, plus additional 1 mg IM when IV lipids discontinued 5
• Oral route is inappropriate for preterm infants 6

High-Risk Infants

For infants with cholestasis, malabsorption, or maternal use of anticoagulants/anticonvulsants:

• IM route is mandatory—oral administration is contraindicated 6, 7
• Repeat doses may be necessary based on coagulation studies 7
• Maternal prophylaxis (10-20 mg/day orally for 15-30 days before delivery) prevents early VKDB in infants of mothers on enzyme-inducing drugs 7

Critical Evidence on Breastfed Infants

Recent studies demonstrate that single IM dose at birth does not fully protect exclusively breastfed infants from late VKDB 8, 9:

• Breastfed infants show vitamin K insufficiency after hospital discharge despite IM prophylaxis 8
• Daily oral supplementation of 150 μg from 2-14 weeks significantly reduces PIVKA-II concentrations (marker of subclinical deficiency) 9
• This finding supports ongoing supplementation for exclusively breastfed infants through 3 months of life 8, 9

Treatment of Active VKDB in Newborns

• Give 1 mg subcutaneous or intramuscular immediately 3
• Higher doses may be necessary if mother received oral anticoagulants 3
• Prompt response (PT shortening in 2-4 hours) is diagnostic of VKDB 3
• Failure to respond indicates alternative diagnosis 3
• Whole blood or component therapy indicated for excessive bleeding, but vitamin K must be given concurrently 3

Pediatric Warfarin Reversal

• For excessive INR (>8) without bleeding: 30 μg/kg IV vitamin K 2
• For significant bleeding: immediate reversal with fresh frozen plasma, prothrombin complex concentrate, or recombinant factor VIIa 2
• Algorithms are extrapolated from adult studies due to limited pediatric data 2

Key Pitfalls to Avoid

• Never use subcutaneous route for urgent reversal—it is unreliable 2, 1
• Do not give high-dose vitamin K (≥10 mg) routinely for elevated INR without bleeding—this creates prolonged warfarin resistance 2
• Do not rely on vitamin K alone for life-threatening bleeding—must combine with clotting factor replacement 2
• Do not assume single IM dose at birth is sufficient for breastfed infants—consider ongoing supplementation 8, 9
• Oral prophylaxis success depends entirely on compliance—IM is more reliable when adherence is uncertain 6